Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological response to a single high-dose vitamin D3 injection in vitamin D-deficient adults
2012-003217-33Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Frequency of CD38+ B-cells. Started Aug 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2012-003217-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003217-33.